The report also covers current competitive scenario and the predicted trend and profiles key vendors including market leaders and important emerging players. The breakdown of national markets by Offering，Application and End User over the forecast years are also included. Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)įor each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031.Geographically, the following national/local markets are fully investigated: The balanced (most likely) projection is used to quantify Asia Pacific nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country.īased on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.īased on Test Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.īy Test Sample, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.īy Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.īy End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. Ğmerging Product Trends & Market Opportunities.In-depth qualitative analyses include identification and investigation of the following aspects:
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. Highlighted with 32 tables and 58 figures, this 121-page report “Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific nutrigenomics market and all its sub-segments through extensively detailed classifications.
Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.
0 kommentar(er)
